Long-term speech outcome in patients with Robin sequence after cleft palate repair and tongue-lip adhesion: A 21-year retrospective analysis.


Journal

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
ISSN: 1878-4119
Titre abrégé: J Craniomaxillofac Surg
Pays: Scotland
ID NLM: 8704309

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 05 06 2021
revised: 21 10 2022
accepted: 22 01 2023
medline: 12 6 2023
pubmed: 29 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

The purpose of this study was to assess the effect of tongue-lip adhesion (TLA) on the long-term speech and articulation outcomes of patients with Robin sequence (RS) after cleft palate repair. Outcomes were compared to those in patients with RS who required positioning alone and to patients with isolated cleft palate (ICP). All consecutive patients with RS (with or without TLA) versus isolated cleft palate (ICP) who underwent cleft palate repair were retrospectively reviewed. Speech and articulation included all assessments between the age of 3-6 years. Secondary speech operations, velopharyngeal insufficiency (VPI), hypernasality, and articulation errors by cleft-type characteristics (CTC), including 4 categories (passive), non-oral, anterior-oral, and posterior-oral. A total of 41 RS patients and 61 ICP patients underwent repair with sufficient follow-up. Of them, 23 patients underwent a TLA at median age of 12 days. Rates of hypernasality (p = 0.004), secondary speech operations (p = 0.004), and posterior oral CTC (p = 0.042) were higher in RS compared to ICP. Isolated RS had speech outcomes similar to those of ICP; however, syndromic RS patients needed more secondary speech operations compared to isolated RS (p = 0.043). TLA-RS patients did not demonstrate differences in speech outcomes or any CTCs (all p > 0.05) compared to non-TLA-RS patients, except for the anterior oral CTC (74% TLA-RS vs 28% non-TLA-RS, p = 0.005). Within the limitations of the study, it seem that TLA does not affect long-term velopharyngeal function in patients with RS. However, TLA-RS patients demonstrated higher rates of anterior-oral CTC, which might be related to a different positioning of the tongue after TLA. Every effort should be taken to treat patients with RS conservatively instead of with TLA because of this demonstrated a negative effect on one type of articulation error. However, if conservative therapy fails, a TLA is still a valuable adjunct in the treatment of RS, and cleft speech pathologists who treat such patients should be more aware of this phenomenon in order to improve long-term articulation outcomes.

Identifiants

pubmed: 37117117
pii: S1010-5182(23)00012-4
doi: 10.1016/j.jcms.2023.01.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

209-216

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors report any conflicts of interest. None of the authors have a financial interest in any of the products, devices, or drugs mentioned in this article.

Auteurs

Robrecht J H Logjes (RJH)

Department of Plastic, Reconstructive, and Handsurgery, Amsterdam UMC, Location VU, PO box 7057, 1007 MB, Amsterdam, the Netherlands; Department of Speech and Language Pathology, Amsterdam UMC, Amsterdam, the Netherlands. Electronic address: r.j.h.logjes@gmail.com.

Joline F Mermans (JF)

Department of Plastic, Reconstructive, and Handsurgery, Amsterdam UMC, Location VU, PO box 7057, 1007 MB, Amsterdam, the Netherlands. Electronic address: j.mermans@amsterdamumc.nl.

Marieke J Coerts (MJ)

ENT Department, Department of Epidemiology & Data Science, Amsterdam UMC, De Boelelaan 1118, 1081 HZ, 1007 MB, Amsterdam, the Netherlands. Electronic address: mj.coerts@amsterdamumc.nl.

Birgit I Lissenberg-Witte (BI)

Department of Epidemiology & Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.

Corstiaan C Breugem (CC)

Department of Plastic, Reconstructive, and Handsurgery, Amsterdam UMC, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. Electronic address: c.c.breugem@amsterdamumc.nl.

J Peter W Don Griot (JPW)

Department of Plastic, Reconstructive, and Handsurgery, Amsterdam UMC, Location VU, PO box 7057, 1007 MB, Amsterdam, the Netherlands. Electronic address: DonGriot@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH